ALB and diabetes mellitus: In this study, our constructed recombinant anti-IL-6R fusion proteins (VHH-0031), by linking 2 single domain chains against the pro-inflammatory cytokine receptor (IL-6R) and human serum albumin (HSA) respectively, presents potent renoprotective effect in diabetes both in vivo and in vitro.